A cohort study evaluating paraaortic lymphadenectomy in endometrial cancer
- Authors:
- Haiyan Zhang
- Zhi Zuo
- Ye Wang
- Li Wang
- Zhiling Zhu
View Affiliations
Affiliations: Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai 200011, P.R. China, Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai 200011, P.R. China
- Published online on: September 17, 2012 https://doi.org/10.3892/ol.2012.919
-
Pages:
1361-1365
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
The current study sought to assess the role of paraaortic lymphadenectomy (LNE) in females with endometrial cancer. A retrospective analysis of patients diagnosed with endometrial cancer of stage IA to II preoperatively, between 2009 and 2011 was conducted. Patients were included who had suffered from endometrial cancer without preoperative adjuvant therapy and who underwent hysterectomy plus systematic pelvic LNE and paraaortic LNE by laparoscopy or laparotomy. A total of 54 patients who underwent surgery for preoperative endometrial cancer were selected. All patients underwent LNE. The incidences of pelvic and paraaortic lymph node metastases were 11.1% (6/54) and 7.4% (4/54), with a total positive lymph node rate of 14.8% (8/54). In addition, among the 8 positive cases, 5 patients underwent laparotomy and 3 underwent laparoscopy; 3 cases were classified as stage I and 5 as stage II preoperatively. Of these, 7 patients were identified with pathology-related risk factors, including low differentiation or clear cell adenocarcinoma postoperatively. Discordance of pathological differentiation between the pre- and postoperative stages reached 57.1% (4/7). The results revealed the high occurrence of positive lymph nodes in endometrial cancer which demonstrate the importance of systematic LNE. Additonally, no severe complications were caused by LNE besides lymph cysts. In summary, it is neccesary to perform LNE, particularly the removal of the paraaortic lymph node, in patients with endometrial cancers in order to improve postoperative therapy. Laparoscopy has similar surgical effects as laparotomy, but has a number of advantages.
View References
1.
|
A JemalA ThomasT MurrayM ThunCancer
statistics, 2002CA Cancer J
Clin522347200210.3322/canjclin.52.1.23
|
2.
|
NF HackerUterine cancerPractical
Gynecologic OncologyJS BerekNF HackerLippincott Williams &
WilkinsPhiladelphia4074552000
|
3.
|
K HirahatakeH HareyamaN SakuragiM NishiyaS
MakinodaS FujimotoA clinical and pathologic study on para-aortic
lymph node metastasis in endometrial carcinomaJ Surg
Oncol658287199710.1002/(SICI)1096-9098(199706)65:2%3C82::AID-JSO3%3E3.0.CO;2-J9209518
|
4.
|
T KamuraH YahataT ShigematsuPredicting
pelvic lymph node metastasis in endometrial carcinomaGynecol
Oncol72387391199910.1006/gyno.1998.528810053111
|
5.
|
AJ MundtKT MurphyJ RotmenschSE WaggonerSD
YamadaPP ConnellSurgery and postoperative radiation therapy in FIGO
stage IIIC endometrial carcinomaInt J Radiat Oncol Biol
Phys5011541160200110.1016/S0360-3016(01)01590-511483324
|
6.
|
DS McMeekinD LashbrookM GoldNodal
distribution and its significance in FIGO stage IIIc endometrial
cancerGynecol Oncol82375379200110.1006/gyno.2001.627811531298
|
7.
|
NL NeubauerJR LurainThe role of
lymphadenectomy in surgical staging of endometrial cancerInt J Surg
Oncol2011814649201122312525
|
8.
|
H ZhangL JiaQ ZhangY ZhangX YangB
KongTherapeutic role of systematic retroperitoneal lymphadenectomy
in endometrial cancerBull Cancer991017201222266042
|
9.
|
HS KimHY KimCY ParkLymphadenectomy
increases the prognostic value of the revised 2009 FIGO staging
system for endometrial cancer: A multi-center studyEur J Surg
Oncol38230237201210.1016/j.ejso.2011.12.02322244682
|
10.
|
G GargRT MorrisL SolomonEvaluating the
significance of location of lymph node metastasis and extranodal
disease in women with stage IIIC endometrial cancerGynecol
Oncol123208213201110.1016/j.ygyno.2011.07.02521821278
|
11.
|
SM KehoeDS MillerThe role of
lymphadenectomy in endometrial cancerClin Obstet
Gynecol54235244201110.1097/GRF.0b013e318218577b21508693
|
12.
|
S Kondalsamy-ChennakesavanS van VugtK
SandayEvaluation of tumor-free distance and depth of myometrial
invasion as prognostic factors for lymph node metastases in
endometrial cancerInt J Gynecol
Cancer2012171221201110.1111/IGC.0b013e3181ef0a3121495232
|
13.
|
JY ParkDY KimJH KimYM KimYT KimJH NamThe
role of pelvic and/or para-aortic lymphadenectomy in surgical
management of apparently early carcinosarcoma of uterusAnn Surg
Oncol17861868201010.1245/s10434-009-0833-619921530
|
14.
|
T HidakaA NakashimaT ShimaT HasegawaS
SaitoSystemic lymphadenectomy cannot be recommended for low-risk
corpus cancerObstet Gynecol Int2010490219201020168975
|
15.
|
H XuY ChenY LiComplications of
laparoscopic radical hysterectomy and lymphadenectomy for invasive
cervical cancer: experience based on 317 proceduresSurg
Endosc21960964200710.1007/s00464-006-9129-017287919
|
16.
|
H NomuraH TsudaN SusumuLymph node
metastasis in grossly apparent stages I and II epithelial ovarian
cancerInt J Gynecol
Cancer20341345201010.1111/IGC.0b013e3181cf627120375794
|
17.
|
Y KornovskiG GorchevNeoadjuvant
chemotherapy followed by radical surgery and radiotherapy vs.
pelvic irradiation in patients with cervical cancer FIGO stage IIB
- IVAJ BUON11291297200617309152
|
18.
|
JJ RassweilerTO HenkelC StockO SeemannT
FredeP AlkenRetroperitoneal laparoscopic lymph node dissection for
staging non-seminomatous germ cell tumors before and after
chemotherapyLymphology29364419968721978
|
19.
|
AH KloppA JhingranL
RamondettaNode-positive adenocarcinoma of the endometrium: outcome
and patterns of recurrence with and without external beam
irradiationGynecol
Oncol115611200910.1016/j.ygyno.2009.06.03519632709
|
20.
|
CA Leath IIITM NumnumJE Kendrick IVPJ
FrederickRP RocconiMG ConnerJM Straughn JrPatterns of failure for
conservatively managed surgical stage I uterine carcinosarcoma:
implications for adjuvant therapyInt J Gynecol
Cancer19888891200910.1111/IGC.0b013e3181a831fb19574779
|
21.
|
JH HongJS ChoiJH LeeLaparoscopic
lymphadenectomy for isolated lymph node recurrence in gynecologic
malignanciesJ Minim Invasive
Gynecol19188195201110.1016/j.jmig.2011.10.01322176995
|
22.
|
A YoonTJ KimWS LeeBG KimDS BaeSingle-port
access laparoscopic staging operation for a borderline ovarian
tumorJ Gynecol
Oncol22127130201110.3802/jgo.2011.22.2.12721860739
|
23.
|
JW BaeJH LeeJS ChoiLaparoscopic
lymphadenectomy for gynecologic malignancies: evaluation of the
surgical approach and outcomes over a seven-year experienceArch
Gynecol Obstet285823829201221847586
|